{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:41:32Z","timestamp":1782823292719,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["4R33AI159937-03"],"award-info":[{"award-number":["4R33AI159937-03"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-024-01058-w","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T16:19:05Z","timestamp":1736266745000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Development of broadly protective influenza B vaccines"],"prefix":"10.1038","volume":"10","author":[{"given":"Chunyang","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavanya","family":"Babujee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pattinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Jester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Maemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"1058_CR1","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","volume":"391","author":"AD Iuliano","year":"2018","unstructured":"Iuliano, A. D. et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391, 1285\u20131300 (2018).","journal-title":"Lancet"},{"key":"1058_CR2","unstructured":"Neumann G., Treanor J., Kawaoka Y. Orthomyxoviruses. in Fields Virology, vol. 1 (eds Knipe D. M., Howley P. M., Whelan S. P. J., Cohen J. I., Damania B., Enquist L., Freed E. O.) (Wolters Kluwer, 2021)."},{"key":"1058_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29402-5","volume":"13","author":"V Dhanasekaran","year":"2022","unstructured":"Dhanasekaran, V. et al. Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination. Nat. Commun. 13, 1721 (2022).","journal-title":"Nat. Commun."},{"key":"1058_CR4","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.vaccine.2009.11.068","volume":"28","author":"RB Belshe","year":"2010","unstructured":"Belshe, R. B., Coelingh, K., Ambrose, C. S., Woo, J. C. & Wu, X. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine 28, 2149\u20132156 (2010).","journal-title":"Vaccine"},{"key":"1058_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/irv.12522","volume":"12","author":"L Jennings","year":"2018","unstructured":"Jennings, L. et al. Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region. Influenza Respir. Viruses 12, 383\u2013411 (2018).","journal-title":"Influenza Respir. Viruses"},{"key":"1058_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.coi.2018.04.002","volume":"53","author":"J Tan","year":"2018","unstructured":"Tan, J., Asthagiri Arunkumar, G. & Krammer, F. Universal influenza virus vaccines and therapeutics: where do we stand with influenza B virus? Curr. Opin. Immunol. 53, 45\u201350 (2018).","journal-title":"Curr. Opin. Immunol."},{"key":"1058_CR7","unstructured":"WHO. 2024. Recommended composition of influenza virus vaccines for use in the 2024 southern hemisphere influenza season. https:\/\/www.who.int\/publications\/m\/item\/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2024-southern-hemisphere-influenza-season#:~:text=For%20quadrivalent%20egg%2D%20or%20cell,the%20B%2FYamagata%20lineage%20component%3A&text=a%20B%2FPhuket%2F3073%2F,Yamagata%20lineage)%2Dlike%20virus."},{"key":"1058_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/imr.12887","volume":"296","author":"H Fukuyama","year":"2020","unstructured":"Fukuyama, H., Shinnakasu, R. & Kurosaki, T. Influenza vaccination strategies targeting the hemagglutinin stem region. Immunol. Rev. 296, 132\u2013141 (2020).","journal-title":"Immunol. Rev."},{"key":"1058_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0126-4","volume":"4","author":"F Broecker","year":"2019","unstructured":"Broecker, F. et al. A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains. NPJ Vaccines 4, 31 (2019).","journal-title":"NPJ Vaccines"},{"key":"1058_CR10","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.1128\/JVI.00137-12","volume":"86","author":"R Hai","year":"2012","unstructured":"Hai, R. et al. Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes. J. Virol. 86, 5774\u20135781 (2012).","journal-title":"J. Virol."},{"key":"1058_CR11","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1128\/JVI.03183-13","volume":"88","author":"F Krammer","year":"2014","unstructured":"Krammer, F. et al. H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge. J. Virol. 88, 2340\u20132343 (2014).","journal-title":"J. Virol."},{"key":"1058_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","volume":"3","author":"F Krammer","year":"2013","unstructured":"Krammer, F. & Palese, P. Influenza virus hemagglutinin stalk-based antibodies and vaccines. Curr. Opin. Virol. 3, 521\u2013530 (2013).","journal-title":"Curr. Opin. Virol."},{"key":"1058_CR13","doi-asserted-by":"publisher","first-page":"10302","DOI":"10.1128\/JVI.01336-12","volume":"86","author":"F Krammer","year":"2012","unstructured":"Krammer, F., Pica, N., Hai, R., Tan, G. S. & Palese, P. Hemagglutinin stalk-reactive antibodies are boosted following sequential infection with seasonal and pandemic H1N1 influenza virus in mice. J. Virol. 86, 10302\u201310307 (2012).","journal-title":"J. Virol."},{"key":"1058_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01715-13","author":"I Margine","year":"2013","unstructured":"Margine, I. et al. Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses. J. Virol. https:\/\/doi.org\/10.1128\/JVI.01715-13 (2013).","journal-title":"J. Virol."},{"key":"1058_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-017-0026-4","volume":"2","author":"R Nachbagauer","year":"2017","unstructured":"Nachbagauer, R. et al. A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies. NPJ Vaccines 2, 26 (2017).","journal-title":"NPJ Vaccines"},{"key":"1058_CR16","doi-asserted-by":"publisher","first-page":"e00286","DOI":"10.1128\/JVI.00286-17","volume":"91","author":"ME Ermler","year":"2017","unstructured":"Ermler, M. E. et al. Chimeric hemagglutinin constructs induce broad protection against influenza B virus challenge in the mouse model. J. Virol. 91, e00286\u201300217 (2017).","journal-title":"J. Virol."},{"key":"1058_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43003-2","volume":"13","author":"MA Carlock","year":"2023","unstructured":"Carlock, M. A. & Ross, T. M. A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages. Sci. Rep. 13, 15911 (2023).","journal-title":"Sci. Rep."},{"key":"1058_CR18","doi-asserted-by":"publisher","first-page":"e0062223","DOI":"10.1128\/mbio.00622-23","volume":"14","author":"S Chiba","year":"2023","unstructured":"Chiba, S., Kong, H., Neumann, G. & Kawaoka, Y. Influenza H3 hemagglutinin vaccine with scrambled immunodominant epitopes elicits antibodies directed toward immunosubdominant head epitopes. mBio 14, e0062223 (2023).","journal-title":"mBio"},{"key":"1058_CR19","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","volume":"96","author":"G Neumann","year":"1999","unstructured":"Neumann, G. et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl Acad. Sci. USA 96, 9345\u20139350 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1058_CR20","doi-asserted-by":"publisher","first-page":"E8296","DOI":"10.1073\/pnas.1616530113","volume":"113","author":"J Ping","year":"2016","unstructured":"Ping, J., Lopes, T. J., Neumann, G. & Kawaoka, Y. Development of high-yield influenza B virus vaccine viruses. Proc. Natl Acad. Sci. USA 113, E8296\u2013E8305 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1058_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1126\/science.1097211","volume":"305","author":"DJ Smith","year":"2004","unstructured":"Smith, D. J. et al. Mapping the antigenic and genetic evolution of influenza virus. Science 305, 371\u2013376 (2004).","journal-title":"Science"},{"key":"1058_CR22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2211616119","volume":"119","author":"ME Rosu","year":"2022","unstructured":"Rosu, M. E. et al. Substitutions near the HA receptor binding site explain the origin and major antigenic change of the B\/Victoria and B\/Yamagata lineages. Proc. Natl Acad. Sci. USA 119, e2211616119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1058_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9695628","volume":"2018","author":"I Kiseleva","year":"2018","unstructured":"Kiseleva, I. et al. Cross-protective efficacy of monovalent live influenza B vaccines against genetically different Lineages of B\/Victoria and B\/Yamagata in Ferrets. Biomed. Res. Int. 2018, 9695628 (2018).","journal-title":"Biomed. Res. Int."},{"key":"1058_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1334670","volume":"15","author":"JD Allen","year":"2024","unstructured":"Allen, J. D. & Ross, T. M. mRNA vaccines encoding computationally optimized hemagglutinin elicit protective antibodies against future antigenically drifted H1N1 and H3N2 influenza viruses isolated between 2018\u20132020. Front. Immunol. 15, 1334670 (2024).","journal-title":"Front. Immunol."},{"key":"1058_CR25","doi-asserted-by":"publisher","first-page":"2356269","DOI":"10.1080\/21645515.2024.2356269","volume":"20","author":"H Shi","year":"2024","unstructured":"Shi, H. et al. Inactivated influenza virus vaccines expressing COBRA hemagglutinin elicited broadly reactive, long-lived protective antibodies. Hum. Vaccin Immunother. 20, 2356269 (2024).","journal-title":"Hum. Vaccin Immunother."},{"key":"1058_CR26","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1016\/j.vaccine.2019.03.018","volume":"37","author":"TM Ross","year":"2019","unstructured":"Ross, T. M. et al. A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains. Vaccine 37, 2369\u20132376 (2019).","journal-title":"Vaccine"},{"key":"1058_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02421-20","volume":"95","author":"GA Sautto","year":"2021","unstructured":"Sautto, G. A., Ecker, J. W. & Ross, T. M. An H1N1 computationally optimized broadly reactive antigen elicits a neutralizing antibody response against an emerging human-infecting Eurasian Avian-Like Swine Influenza Virus. J. Virol. 95, e0242120 (2021).","journal-title":"J. Virol."},{"key":"1058_CR28","doi-asserted-by":"publisher","first-page":"e00333","DOI":"10.1128\/JVI.00333-19","volume":"93","author":"W Sun","year":"2019","unstructured":"Sun, W. et al. Development of influenza B universal vaccine candidates using the \u201cMosaic\u201d Hemagglutinin approach. J. Virol. 93, e00333\u201319 (2019).","journal-title":"J. Virol."},{"key":"1058_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.746447","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Mosaic hemagglutinin-based whole inactivated virus vaccines induce broad protection against influenza B virus challenge in mice. Front. Immunol. 12, 746447 (2021).","journal-title":"Front. Immunol."},{"key":"1058_CR30","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/s41591-020-0937-x","volume":"26","author":"JK Park","year":"2020","unstructured":"Park, J. K. et al. Pre-existing immunity to influenza virus hemagglutinin stalk might drive selection for antibody-escape mutant viruses in a human challenge model. Nat. Med. 26, 1240\u20131246 (2020).","journal-title":"Nat. Med."},{"key":"1058_CR31","doi-asserted-by":"publisher","first-page":"e00946","DOI":"10.1128\/JVI.00946-18","volume":"93","author":"JD Allen","year":"2019","unstructured":"Allen, J. D., Jang, H., DiNapoli, J., Kleanthous, H. & Ross, T. M. Elicitation of protective antibodies against 20 years of future H3N2 cocirculating influenza virus variants in ferrets preimmune to historical H3N2 influenza viruses. J. Virol. 93, e00946\u201318 (2019).","journal-title":"J. Virol."},{"key":"1058_CR32","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.vaccine.2022.12.005","volume":"41","author":"S Chiba","year":"2023","unstructured":"Chiba, S. et al. Ferret model to mimic the sequential exposure of humans to historical H3N2 influenza viruses. Vaccine 41, 590\u2013597 (2023).","journal-title":"Vaccine"},{"key":"1058_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-019-0433-6","author":"K Takada","year":"2019","unstructured":"Takada, K. et al. A humanized MDCK cell line for the efficient isolation and propagation of human influenza viruses. Nat. Microbiol. https:\/\/doi.org\/10.1038\/s41564-019-0433-6 (2019).","journal-title":"Nat. Microbiol."},{"key":"1058_CR34","doi-asserted-by":"publisher","first-page":"9896","DOI":"10.1128\/JVI.01118-06","volume":"80","author":"E Bottcher","year":"2006","unstructured":"Bottcher, E. et al. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J. Virol. 80, 9896\u20139898 (2006).","journal-title":"J. Virol."},{"key":"1058_CR35","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/molbev\/mst010","volume":"30","author":"K Katoh","year":"2013","unstructured":"Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30, 772\u2013780 (2013).","journal-title":"Mol. Biol. Evol."},{"key":"1058_CR36","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1093\/bioinformatics\/btz305","volume":"35","author":"AM Kozlov","year":"2019","unstructured":"Kozlov, A. M., Darriba, D., Flouri, T., Morel, B. & Stamatakis, A. RAxML-NG: a fast, scalable and user-friendly tool for maximum likelihood phylogenetic inference. Bioinformatics 35, 4453\u20134455 (2019).","journal-title":"Bioinformatics"},{"key":"1058_CR37","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41588-021-00862-7","volume":"53","author":"Y Turakhia","year":"2021","unstructured":"Turakhia, Y. et al. Ultrafast Sample placement on Existing tRees (UShER) enables real-time phylogenetics for the SARS-CoV-2 pandemic. Nat. Genet. 53, 809\u2013816 (2021).","journal-title":"Nat. Genet."},{"key":"1058_CR38","doi-asserted-by":"publisher","first-page":"7417","DOI":"10.1128\/JVI.00808-15","volume":"89","author":"PS Lee","year":"2015","unstructured":"Lee, P. S., Zhu, X., Yu, W. & Wilson, I. A. Design and structure of an engineered disulfide-stabilized influenza virus hemagglutinin trimer. J. Virol. 89, 7417\u20137420 (2015).","journal-title":"J. Virol."},{"key":"1058_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","volume":"108","author":"H Niwa","year":"1991","unstructured":"Niwa, H., Yamamura, K. & Miyazaki, J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193\u2013199 (1991).","journal-title":"Gene"},{"key":"1058_CR40","doi-asserted-by":"publisher","DOI":"10.7717\/peerj-cs.1516","volume":"9","author":"O Abril-Pla","year":"2023","unstructured":"Abril-Pla, O. et al. PyMC: a modern, and comprehensive probabilistic programming framework in Python. PeerJ Comput. Sci. 9, e1516 (2023).","journal-title":"PeerJ Comput. Sci."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-01058-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-01058-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-01058-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T04:40:08Z","timestamp":1736311208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-01058-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1058"],"URL":"https:\/\/doi.org\/10.1038\/s41541-024-01058-w","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.K. has received grant support from Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Inc., Otsuka Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., Otsuka Pharmaceutical, KM Biologics, Kyoritsu Seiyaku, Shinya Corporation, and Fuji Rebio. Y.K. and G.N. are co-founders of FluGen. The other authors have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}